The injury response to DNA damage in live tumor cells promotes antitumor immunity.
2021
Although immune checkpoint blockade (ICB) has strong clinical benefit for treating some tumor types, it fails in others, indicating a need for additional modalities to enhance the ICB effect. Here,...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
60
References
0
Citations
NaN
KQI